Kanna is a South African succulent plant used as an oral supplement for stress resilience, mental flexibility, and sleep. Standardized oral extract (Zembrin, 25 mg daily) shows moderate evidence for calming the brain's threat response, improving mental flexibility and agility, and helping fall asleep, while anxiety and mood evidence is weak and conflicting. Oral use is well tolerated, avoids antidepressants and unverified powders, and relies on small manufacturer-funded trials. (Full Review)
| Marker | Target | Why |
|---|---|---|
| HAM-D Score | < 8 points (conventional reference range: 0–7 points) | Safety check and expected change: screens out clinical depression (≥ 8 points excludes self-directed use) and tracks sleep-onset subscale improvement. |
| Seated Heart Rate (Resting and Post-Stressor) | No established target; blunting of pre-stressor heart rate rise from individual baseline | Expected change and safety check: 25 mg Zembrin blunts anticipatory heart rate spikes; resting tachycardia (> 100 beats per minute) is a discontinuation threshold (paired with seated blood pressure). |
| Computerized Executive Function & Cognitive Flexibility | No established target; improvement from individual baseline score | Expected change: 25 mg/day Zembrin improved executive function and cognitive set flexibility scores over 3 weeks on the CNS Vital Signs battery. |
| Morning Serum Cortisol & Total Testosterone | Cortisol: 5–25 mcg/dL; Testosterone: 300–1,000 ng/dL in males, 15–70 ng/dL in females (standard reference range) | Safety check: high-mesembrine extract inhibits adrenal CYP17A1, 3β-HSD, and 17β-HSD in vitro; values falling below range warrant discontinuation (paired with free testosterone and LH at 3 months). |
Cadence: Baseline (HAM-D score, seated heart rate and blood pressure, computerized executive function, morning fasting cortisol and total testosterone, plus baseline-only complete blood counts, metabolic panels, and liver-kidney tests to screen out hepatic or renal impairment); week 1 (seated heart rate and blood pressure, 60–120 min post-dose); weeks 3–4 (executive cognition 1–2 h post-dose and sleep-onset latency); every 3–6 months (morning fasting cortisol, total and free testosterone, and LH).